These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2487544

  • 21. Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog.
    Montastruc JL, Gaillard-Plaza G, Montastruc P.
    Clin Exp Hypertens A; 1984; 6(10-11):1825-8. PubMed ID: 6398140
    [Abstract] [Full Text] [Related]

  • 22. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P, Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A.
    Am J Cardiol; 1982 Apr 21; 49(6):1574-6. PubMed ID: 6280486
    [Abstract] [Full Text] [Related]

  • 23. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients.
    Manhem P, Bramnert M, Hulthén UL, Hökfelt B.
    Eur J Clin Invest; 1981 Oct 21; 11(5):389-95. PubMed ID: 6800810
    [Abstract] [Full Text] [Related]

  • 24. Cardiovascular and endocrine effects of naloxone compared in normotensive and hypertensive patients.
    Fuenmayor N, Cubeddu L.
    Eur J Pharmacol; 1986 Jul 31; 126(3):189-97. PubMed ID: 3758170
    [Abstract] [Full Text] [Related]

  • 25. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 26. Ketanserin and captopril interaction in the treatment of essential hypertensives.
    Lavezzaro G, Ladetto PE, Valente M, Stramignoni D, Zanna C, Assogna G, Salvetti A.
    Cardiovasc Drugs Ther; 1990 Jan 15; 4 Suppl 1():119-22. PubMed ID: 2285641
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ, Holly JM, Goodwin FJ, Sharman VL, Marsh FP.
    Eur J Clin Pharmacol; 1983 Jan 15; 25(6):721-8. PubMed ID: 6319152
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Acute and chronic effects of captopril on bicyclo-PGEm, the stable bicyclic end product of prostaglandin E2 in essential hypertension.
    Stanek B, Silberbauer K.
    Nephron; 1986 Jan 15; 44(1):40-5. PubMed ID: 3528880
    [Abstract] [Full Text] [Related]

  • 33. Failure of naloxone to reduce the clonidine induced reduction of blood pressure and plasma noradrenaline in patients with essential hypertension.
    Bramnert M, Hökfelt B.
    Acta Physiol Scand; 1983 Aug 15; 118(4):379-83. PubMed ID: 6314747
    [Abstract] [Full Text] [Related]

  • 34. Effect of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive patients on hemodialysis.
    Kaneda H, Murata T, Matsumoto J, Maeta T, Shitomi K, Haruyama T.
    Tohoku J Exp Med; 1982 May 15; 137(1):21-31. PubMed ID: 7048628
    [Abstract] [Full Text] [Related]

  • 35. Abnormal renin short feedback loop in essential hypertension is reversible with converting enzyme inhibition.
    LeBoff Ms, Dluhy RG, Hollenberg NK, Moore TJ, Koletsky RJ, Williams GH.
    J Clin Invest; 1982 Aug 15; 70(2):335-41. PubMed ID: 6284799
    [Abstract] [Full Text] [Related]

  • 36. The hypotensive effect of single-dose captopril in diabetics.
    Chimori K, Miyazaki S, Kosaka J, Sakanaka A, Yasuda K, Miura K.
    Clin Exp Hypertens A; 1986 Aug 15; 8(7):1231-45. PubMed ID: 3095004
    [Abstract] [Full Text] [Related]

  • 37. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL, Willard DA.
    J Clin Pharmacol; 1984 Aug 15; 24(8-9):351-9. PubMed ID: 6384279
    [Abstract] [Full Text] [Related]

  • 38. The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system.
    Quilley J, Duchin KL, Hudes EM, McGiff JC.
    J Hypertens; 1987 Feb 15; 5(1):121-8. PubMed ID: 3295035
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular responses of conscious DOCA-salt hypertensive rats to acute intracerebroventricular and intravenous administration of captopril.
    Pochiero M, Nicoletta P, Losi E, Bianchi A, Caputi AP.
    Pharmacol Res Commun; 1983 Feb 15; 15(2):173-82. PubMed ID: 6342005
    [Abstract] [Full Text] [Related]

  • 40. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I, Brown MJ, Dollery CT.
    Clin Exp Hypertens (1978); 1980 Feb 15; 2(6):935-45. PubMed ID: 7004806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.